Badger
发表于 2025-3-27 00:09:30
http://reply.papertrans.cn/47/4603/460277/460277_31.png
kidney
发表于 2025-3-27 04:55:40
atic potential of these cell-lines i.e. tumour progression. The role of HYAL1 is more controversial, but the present study suggests that in some cell-lines this may also play a role in the progression of tumours to a metastatic/ angiogenic phenotype.
CT-angiography
发表于 2025-3-27 08:47:52
pports dynamic tissue remodeling for regeneration and the clinical application of HGF for treatment of organ failure/fibrosis will be initiated within a few years. These “two-pronged approaches” regarding HGF will lead to tissue repair and perhaps even the prevention of cancer.
DOTE
发表于 2025-3-27 12:56:01
Furthermore, the tumor microcirculation creates barriers that hinder drug delivery to the tumor mass. Systemic chemotherapy often reduces tumor burden but rarely is effective in completely eliminating the tumor. This has created the need for the development of more effective cancer therapies. To th
dissent
发表于 2025-3-27 16:37:41
http://reply.papertrans.cn/47/4603/460277/460277_35.png
Callus
发表于 2025-3-27 20:58:19
semination are enhanced while the tumor can generate a matrix supporting neoangiogenesis. In the unique tumor microenvironment, both endothelial cells and tumor cells express a wide variety of factors, including procoagulants, cell adhesion molecules, vasomotor substances and cell survival signals.
MAL
发表于 2025-3-27 22:29:18
1615-1844 pdate edition of all relevant data. For each individual substance the information is presented in userfriendly documents, containing data, figures and references. Easy access to the documents is provided via substance and property keywords, listings and full text retrieval.978-3-540-31359-5Series ISSN 1615-1844 Series E-ISSN 1616-9522
ENDOW
发表于 2025-3-28 03:16:45
gists, immunologists, stem cell researchers, oncology and hematology fellows (trainees), oncology educators (graduate and undergraduate levels), and course book for graduate students and undergraduate students..978-90-481-8160-5978-1-4020-9576-4
Reverie
发表于 2025-3-28 09:06:22
List of frequently used symbols and abbreviations, conversion factors,
VEST
发表于 2025-3-28 10:38:20
I-VII compounds comparative tables on crystal structure of phases at normal conditions,